Journal article
Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysis
A Hunter, CH Marck, E Butler, M Allan, KL Edward, A Giles, J Kulkarni, D Rajendran, S Shaw, LB Grech
Multiple Sclerosis and Related Disorders | Published : 2021
Abstract
Background: Depression is common in people with multiple sclerosis (MS), yet often goes undetected, untreated or undertreated. Objective: This qualitative research explored current practices, barriers and facilitators for detection and treatment of depression in Australians with MS. Methods: Participants were 26 people with MS recruited through social media. Participants completed the Centre for Epidemiological Studies Depression-Revised (CESD-R) scale and in-depth telephone or video interviews. Interviews were analysed using framework analysis. Results: Scores measured on the CESD-R proposed 73% of participants were experiencing severe depression symptoms. Participants reported that depress..
View full abstractGrants
Awarded by Merck
Funding Acknowledgements
The research leading to these results received funding an incubator grant provided by Multiple Sclerosis Research Australia, grant number19-0723. CMH was supported by a Fellowship from the National Health and Medical Research Council and Multiple Sclerosis Research Australia. LBG was supported by a Fellowship from Multiple Sclerosis Research Australia. LBG, MA and EB have received from Merck Global for unrelated research.